GSK plc ADR
Price
Key statistics
- Forward rate
- $1.81
- Yield
- 3.84%
- Payout ratio
- 56.55%
- Frequency
- Quarterly
- 2026-08-14$0.45
GSK plc ADR is an American depositary receipt representing two ordinary shares of GSK plc, a United Kingdom-based biopharmaceutical company. It provides U.S. investors with access to GSK’s healthcare business through a US-traded instrument tied to the company’s underlying ordinary shares. GSK focuses on pharmaceuticals, vaccines, and specialty medicines, with commercial activity centered on respiratory, immunology and inflammation, oncology, HIV, and infectious diseases. Its current portfolio includes products used in areas such as asthma, cancer, autoimmune disorders, and infectious disease prevention and treatment. The company operates through Commercial Operations and Research and Development, combining drug development with global commercialization of approved therapies. GSK plc ADR plays a role in the market as a widely followed healthcare security that reflects the performance of a multinational medicines and vaccines business with established reach across major therapeutic categories.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Mr. Luke Victor Miels
- Employees
- 66,841
- Headquarters
- London, United Kingdom
- Website
- www.gsk.com